Evaluation of Bone Mineral Density in Treatment-naive Patients with Human Immundeficiency Virus Infection
Objective:Human Immundeficiency virus (HIV) infection is a risk factor for low bone mineral density (BMD). International HIV/AIDS guidelines do not recommend BMD screening for every patient. In this study, we aimed to compare the risk factors for the development of osteoporosis/osteopenia between pa...
Main Authors: | Sevtap Şenoğlu, Özlem Altuntaş Aydın |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2020-08-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: |
http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/evaluation-of-bone-mineral-density-in-treatment-na/39782
|
Similar Items
-
ASSOCIATION OF SERUM P1NP (N-TERMINAL PROPEPTIDE OF TYPE1 COLLAGEN) AND BONE MINERAL DENSITY (BMD) IN OSTEOPOROSIS
by: Afshan Iftikhar, et al.
Published: (2018-04-01) -
Evaluation of Bone Mineral Density in Iranian HIV/AIDS Patients
by: Banafsheh Moradmand Badie, et al.
Published: (2011-07-01) -
Evaluation of Bone Mineral Density in Iranian HIV/AIDS Patients
by: Minoo Mohraz, et al.
Published: (2011-07-01) -
Periodontitis and bone mineral density among pre and post menopausal women: A comparative study
by: Suresh Snophia, et al.
Published: (2010-01-01) -
Association of bone mineral density with trichlorophenol: a population-based study
by: Zijian Yan, et al.
Published: (2023-03-01)